EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The timed 100 mL water swallow test for patients with head and neck cancer: What constitutes a clinically significant difference?

Jenan A Altamimi iD, Janet A Wilson, Justin Roe, Joanne M Patterson

Head & Neck · 2024

DOI: 10.1002/hed.27885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Jenan A Altamimi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kuwait Cancer Control Centre, Ministry of Health, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Deglutition Disorders, Deglutition, Minimal Clinically Important Difference. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Swallowing function in patients with head and neck cancer (HNC) is often assessed pre‐treatment, during and at intervals post‐treatment to identify those with dysphagia as early as possible. This study aims to investigate the minimal clinical important difference (MCID) for the 100 mL water swallow test (100 mL WST) to increase its utility in clinical practice and in clinical trials.

Methods

Data from 211 HNC patients, treated by either single or combined modality were included. Patients completed both the 100 mL WST and M.D. Anderson Dysphagia Inventory (MDADI) at baseline (i.e., prior to treatment) and 12 months post‐treatment. The MCID for the 100 mL WST was calculated using two approaches of the anchor‐based method (using the MDADI), including mean change, and ROC curve. Additionally, the distribution‐based method was used utilizing the half standard deviation approach.

Results

In the anchor‐based method, a 4 mL/s in the 100 mL WST was defined as an MCID for deterioration, with a sensitivity of 75% and a 1‐specificity of 46%. In contrast, a change of 5 mL/s was deemed as an MCID for improvement, based on the distribution‐based method.

Conclusion

The findings showed that deterioration of 4 mL, or an increase of 5 mL from baseline to 12 months post‐HNC treatment equates to an MCID from the patients' perspective. Based on these findings, it may be beneficial to increase the utilization of the 100 mL WST in clinical practice to observe the changes, and in clinical trials to interpret and compare different study arms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsDeglutition DisordersDeglutitionMinimal Clinically Important DifferenceHumansMaleFemaleMiddle AgedAgedAdultWaterAged, 80 and overROC CurveSensitivity and Specificity

Stichwörter der Autor:innen

dysphagiahead and neck cancerminimal clinical important differencewater swallow test

Substanzen

Water

Autor:innen und Institutionen

  • Kuwait Cancer Control Centre, Ministry of Health, Kuwait City, Kuwait.
  • Institute of Population Health/Liverpool Head and Neck Centre, University of Liverpool, Liverpool, UK.
  • Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Department of Speech, Voice and Swallowing, The Royal Marsden NHS Foundation Trust, London, UK.
  • Department of Otolaryngology - Head and Neck Surgery, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Surgery and Cancer, Imperial College London, London, UK.

ORCID-Profile: Jenan A Altamimi

Zitieren

APA

Altamimi, J. A., Wilson, J. A., Roe, J., & Patterson, J. M. (2024). The timed 100 mL water swallow test for patients with head and neck cancer: What constitutes a clinically significant difference?. Head & Neck. https://doi.org/10.1002/hed.27885

Vancouver

Altamimi JA, Wilson JA, Roe J, Patterson JM. The timed 100 mL water swallow test for patients with head and neck cancer: What constitutes a clinically significant difference?. Head & Neck. 2024. doi:10.1002/hed.27885

BibTeX
@article{Altamimi2024,
  author = {Altamimi, Jenan A and Wilson, Janet A and Roe, Justin and Patterson, Joanne M},
  title = {The timed 100 mL water swallow test for patients with head and neck cancer: What constitutes a clinically significant difference?},
  journal = {Head & Neck},
  year = {2024},
  doi = {10.1002/hed.27885}
}
Kostenlos starten →